Sonamukhi (Senna) for Constipation: Dosage and Treatment Plan
Start with 8.6–17.2 mg daily of senna (sennosides) and titrate upward based on symptom response, with a practical maximum of 4 tablets twice daily (approximately 68.8 mg/day), recognizing that senna is best reserved for short-term use or rescue therapy due to unknown long-term safety. 1
Initial Dosing Strategy
- Begin with 8.6–17.2 mg daily (equivalent to 1-2 standard tablets containing 8.6 mg sennosides each), taken at bedtime 1
- For liquid formulations, the FDA-approved dosing for adults is 2-3 teaspoons (10-15 mL) once daily at bedtime 2
- Senna works as a stimulant laxative by inducing colonic contractions and improving motility without significantly altering stool consistency 3
Dose Titration
- Titrate upward gradually based on symptom response and tolerability 1
- The recommended maximum is 4 tablets twice daily (approximately 68.8 mg/day total), though guidelines note "no clear maximum dose" 1
- For liquid formulations, maximum dosing is 3 teaspoons (15 mL) twice daily for adults 2
- Allow adequate time between dose adjustments, as bowel response may take 6-12 hours 2
Treatment Duration and Role in Therapy
Senna should be used primarily for short-term treatment or as rescue therapy because long-term safety and efficacy remain unknown 1. This is a critical caveat that distinguishes senna from osmotic laxatives like polyethylene glycol, which have demonstrated durable 6-month safety profiles 1.
When to Use Senna:
- As a cost-effective first-line option (estimated monthly cost <$50) 1
- For rescue therapy when osmotic laxatives provide insufficient relief 1
- When rapid bowel stimulation is needed due to its mechanism of inducing colonic propulsion 3
Common Side Effects and Management
- Abdominal cramping and discomfort are the most frequent limiting side effects 1
- Diarrhea and electrolyte imbalances can occur with prolonged or excessive use 1
- Perineal blistering is a rare but important side effect (2.2% incidence in one pediatric series), occurring primarily with higher doses (>60 mg/day) and prolonged stool-to-skin contact 4
- Minor side effects like vomiting occur in approximately 13% of patients but typically resolve with dose adjustment 4
Important Clinical Caveats
Dosing Challenges:
- Senna is present in many laxative teas where precise dosing is difficult to calculate, making standardized tablet or liquid formulations preferable 1
- Ensure patients understand the difference between sennosides content (active ingredient) and total senna leaf content when comparing products 1
Long-term Considerations:
- Despite historical concerns, no evidence of tolerance development has been documented in systematic reviews 4
- The lack of long-term safety data means senna should not be the default maintenance therapy for chronic idiopathic constipation 1
- Consider transitioning to osmotic laxatives (polyethylene glycol, lactulose) or prescription secretagogues (linaclotide, plecanatide) for sustained management 1
Special Populations
Pediatric Dosing (FDA-approved):
- Ages 6-12 years: 1 to 1.5 teaspoons (5-7.5 mL) once daily, maximum 1.5 teaspoons twice daily 2
- Ages 2-6 years: 0.5 to 0.75 teaspoons (2.5-3.75 mL) once daily, maximum 0.75 teaspoons once daily 2
- Under 2 years: Consult a physician 2
- In children with anorectal malformations, senna demonstrated superior effectiveness compared to polyethylene glycol (p=0.026) 3
Pregnancy:
- While senna can be used, lactulose is the only osmotic laxative specifically studied in pregnancy and may be preferred 1
Practical Algorithm for Treatment
- Start with 8.6-17.2 mg daily at bedtime for cost-effective initial management 1
- Assess response after 24-48 hours and titrate upward if constipation persists 1
- If requiring doses >34.4 mg/day (4 tablets daily) or treatment beyond 2-4 weeks, transition to osmotic laxatives (polyethylene glycol 17g daily) for better-established long-term safety 1
- Reserve higher doses (up to 4 tablets twice daily) strictly for rescue therapy or short-term breakthrough constipation 1
- If symptoms persist despite maximum senna dosing, consider prescription agents like linaclotide (72-145 μg daily) or prucalopride (1-2 mg daily) 1